Thus, SCFA (mainly butyrate) prevent diet-induced obesity by inhibiting HDAC3 activity in IECs, and attempts to regulate the butyrate-HDAC3 pathway may be used to prevent and ameliorate obesity-related diseases. Here, HDAC3 is linked to obesity due to melanocortin 4 receptor deficiency.